欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/1503/001
药品名称Irinotecan HCl-trihydraat Fresenius 20 mg/ml concentrate for solution for infusion
活性成分
    • Irinotecan hydrochloride 20.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi Nederland BV Amersfoortseweg 10 E 3712BC Huis ter Heide Nederland
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Slovenia (SI)
    • Luxembourg (LU)
    • Iceland (IS)
    • Portugal (PT)
    • Bulgaria (BG)
    • Romania (RO)
      Irinotecan Kabi 20 mg/ml concentrat pentru solutie perfuzabila
    • Malta (MT)
    • Germany (DE)
      Irinotecan advisors 20 mg/ml Konzentrat für Lösungen für Infusionen
    • Belgium (BE)
    • Austria (AT)
      Irinotecan Kabi 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Sweden (SE)
    • Norway (NO)
许可日期2008/12/02
最近更新日期2024/12/21
药物ATC编码
    • L01XX19 irinotecan
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase